Technology Networks reports that people with the fatty liver disease MASLD who took GLP-1 drugs had lower mortality and fewer hospital stays.
Recap by typeshit. Full story at Technology Networks.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Cheap Medicine Shop and Online Generic Medicine got warning letters in September for selling Semanext and Semanat injections to US buyers without approval.
A short Facebook post sets out how the three popular weight loss and diabetes shots differ from each other.
Loading…